Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Point-of-care Diagnostic Framework for Fibromyalgia Using Integrated Vibrational Spectroscopy and Metabolomics.

Research square·2026
Same author

Depression, pain, and functional impairment across fibromyalgia, rheumatoid arthritis, and systemic lupus erythematosus: A cross-condition analysis and mediation model.

Journal of psychosomatic research·2026
Same author

scDIG: An R Shiny Application for Interactive Density-Based Gating of Single-Cell Proteomic and Transcriptomic Data.

bioRxiv : the preprint server for biology·2026
Same author

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Blood advances·2026
Same author

Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programs.

Blood·2026
Same author

WayFindR: investigating feedback in biological pathways.

NAR genomics and bioinformatics·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
Same journal

Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis.

Cancers·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

3.5K

PLASMA: Partial LeAst Squares for Multiomics Analysis.

Kyoko Yamaguchi1, Salma Abdelbaky1, Lianbo Yu2

  • 1Division of Hematology, Department of Internal Medicine, Ohio State University, Columbus, OH 43210, USA.

Cancers
|January 25, 2025
PubMed
Summary
This summary is machine-generated.

We developed PLASMA, a novel supervised method for integrating multiomics data to predict patient survival outcomes. This algorithm effectively identifies high-risk and low-risk patients, outperforming existing methods.

Keywords:
esophageal cancergastric cancermultiomicsoverall survivalsupervised learning

More Related Videos

Isolation of Nuclei from Flash-Frozen Liver Tissue for Single-Cell Multiomics
09:09

Isolation of Nuclei from Flash-Frozen Liver Tissue for Single-Cell Multiomics

Published on: December 9, 2022

5.5K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.1K

Related Experiment Videos

Last Updated: May 5, 2026

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

3.5K
Isolation of Nuclei from Flash-Frozen Liver Tissue for Single-Cell Multiomics
09:09

Isolation of Nuclei from Flash-Frozen Liver Tissue for Single-Cell Multiomics

Published on: December 9, 2022

5.5K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.1K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • High-throughput "omics" technologies generate vast datasets, necessitating advanced methods for multi-omics data integration.
  • Supervised learning methods for multi-omics integration, particularly for survival prediction, are less developed than unsupervised approaches.

Purpose of the Study:

  • To introduce PLASMA, the first supervised algorithm capable of predicting time-to-event outcomes from multi-omics data.
  • To address challenges in multi-omics data integration, including handling datasets with missing omics assays for some samples.

Main Methods:

  • PLASMA employs a two-layer partial least squares (PLS) approach to identify components correlating with outcomes.
  • It constructs a joint Cox proportional hazards model using these selected components.
  • The algorithm can learn from multi-omics data even when samples have been assayed on only a subset of omics data.

Main Results:

  • PLASMA successfully predicted risk stratification in stomach adenocarcinoma (STAD) and esophageal adenocarcinoma (ESCA) patient data.
  • The model demonstrated superior performance compared to individually trained omics models and the unsupervised Multi-Omics Factor Analysis (MOFA) method.
  • A negative comparison using dissimilar ESCA squamous cell carcinomas showed no significant risk separation (p = 0.57), validating PLASMA's specificity.

Conclusions:

  • PLASMA provides a powerful supervised approach for multi-omics data integration and survival prediction.
  • The identified predictive factors within the PLASMA model are biologically justifiable.
  • This method advances the field of personalized medicine by enabling more accurate patient risk stratification.